Kaohsiung Medical University Hospital
Kaohsiung City, 80756, Taiwan
NCT Number: NCT04952363
Although whole body vibration (WBV) is mainly designed to promote neuromuscular function, however, because of its vibration characteristics, whether it can provide additional effects on the sputum clearance for chronic obstructive pulmonary (COPD) disease patients, thereby improving the quality of life, and exercise capacity is still unknown.
Looking for future studies?
Notify Me35 year–90 year
All sexes
Interventional
Not applicable
Kaohsiung City, 80756, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects received the interventions twice a week for 8 weeks. HFCWO+WBVT group received additional 30 minutes WBVT treatment. In every WBVT session, three rounds of 3 minutes of vibration (amplitude: 2 mm; frequency: 20 Hz) were provided, with a 60-second rest between rounds.
Subjects received the interventions twice a week for 8 weeks. The HFCWO was delivered by a respiratory therapist using a percussive vest at 10-13 Hz oscillating frequency and at a pressure setting of 2 cm H2O. The treatment duration was 25 minutes, and the participants remained in a sitting position.
Time frame: 8 weeks
forced vital capacity tested in pulmonary function test (Liters)
Time frame: 8 weeks
forced expiratory volume in 1 second in pulmonary function test (Liters)
Time frame: 8 weeks
forced expiratory volume in 1 second divided by forced vital capacity in pulmonary function test (%)
Time frame: 8 weeks
percentage of predicted FVC value (% pred)
Time frame: 8 weeks
percentage of predicted FEV1 value (% pred)
Time frame: 8 weeks
the distance walked in 6 minutes (m)
Time frame: 8 weeks
percentage of the predicted 6 minute walk test distance (%pred)
Time frame: 8 weeks
the product of distance walked and lowest oxygen saturation during the 6-min walk test (m%)
Time frame: 8 weeks
the number of repetitions performed in the 1-min sit-to-stand test (rep.)
Time frame: 8 weeks
the complete time for the 5-repetition sit-to-stand test (sec)
Time frame: 8 weeks
Maximal force output for biceps femoris muscle (lbs)
Time frame: 8 weeks
maximal force output for quadriceps muscle (lbs)
Time frame: 8 weeks
questionnaire of sputum volume, it contained three items (0-25 mL/d, 25-50 mL/d, and 50-100 mL/d) as a checklist
Time frame: 8 weeks
the evaluation of the chest radiography based on the sputum impaction score, scores ranging from 0 to 18. A decrease in score represented an improvement in sputum in each area.
Time frame: 8 weeks
questionnaire of dyspnea, scores ranging from 0 (low degree of dyspnea) to 4 (high degree of dyspnea)
Time frame: 8 weeks
questionnaire of COPD symptoms, scores ranging from 0 to 40, higher scores indicating more severe impact of COPD on their life
Time frame: 8 weeks
questionnaire of overall health, daily life, and perceived well-being, scores ranging from 0 (no health impairment) to 100 (maximum health impairment)
Kaohsiung Medical University Chung-Ho Memorial Hospital
Other
The Effect of Whole Body Vibration Training on Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details